Haemonetics Corp/ US4050241003 /
| 2024-04-19 5:36:01 PM | Chg. -1.84 | Volume | Bid5:36:01 PM | Ask5:36:01 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 81.62USD | -2.20% | 159,934 Turnover: 9.52 mill. |
81.57Bid Size: 100 | 81.78Ask Size: 400 | 4.13 bill.USD | - | 35.86 |
Assets
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 337.6340 | 323.8620 | 332.1560 | 343.9790 | 253.3990 | ||||||
| Intangible Assets | 204.4580 | 177.5400 | 156.5890 | 127.6930 | 133.1060 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 831.0420 | 728.6800 | 716.1620 | 698.6460 | 663.4710 | ||||||
| Inventories | 187.0280 | 176.9290 | 160.7990 | 194.3370 | 270.2760 | ||||||
| Accounts Receivable | 157.0930 | 152.6830 | 151.2260 | 185.0270 | 165.2070 | ||||||
| Cash and Cash Equivalents | 115.1230 | 139.5640 | 180.1690 | 169.3510 | 137.3110 | ||||||
| Current Assets | 488.0860 | 510.0290 | 521.1770 | 576.1210 | 603.6390 | ||||||
| Total Assets | 1,319.1280 | 1,238.7090 | 1,237.3390 | 1,274.7670 | 1,267.1100 | ||||||
Liabilities
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 39.6740 | 42.9730 | 55.2650 | 63.3610 | 50.7300 | ||||||
| Long-term debt | 364.5290 | 253.6250 | 59.4230 | 322.4540 | 305.5130 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 21.4000 | 12.1000 | 6.5000 | 19.9000 | 10.6000 | ||||||
| Liabilities | 597.5630 | 499.0990 | 484.9100 | 606.8990 | 680.0010 | ||||||
| Share Capital | .5090 | .5230 | .5230 | .5100 | .5030 | ||||||
| Total Equity | 721.5650 | 739.6100 | 752.4290 | 667.8680 | 587.1090 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 1,319.1280 | 1,238.7090 | 1,237.3390 | 1,274.7670 | 1,267.1100 | ||||||
Income Statement
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 908.8320 | 886.1160 | 903.9230 | 967.5790 | 988.4790 | ||||||
| Depreciation (total) | 89.9110 | 89.7330 | 89.2470 | 109.4180 | 110.2890 | ||||||
| Operating Result | -43.9420 | -19.3810 | 56.1570 | 83.5450 | 103.3510 | ||||||
| Interest Income | -9.4740 | -8.0950 | -4.5250 | -9.9120 | -16.1990 | ||||||
| Income Before Taxes | -53.4160 | -27.4760 | 59.6320 | 73.6330 | 87.1520 | ||||||
| Income Taxes | 2.1630 | -1.2080 | 14.0600 | 18.6140 | 10.6000 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -55.5790 | -26.2680 | 45.5720 | 55.0190 | 76.5260 | ||||||
Per Share
Cash Flow
| 2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 121.8650 | 159.7380 | 220.3500 | 159.2810 | 158.2170 | ||||||
| Cash Flow from Investing Activities | -104.7680 | -73.3130 | -63.0410 | -116.1480 | -57.1760 | ||||||
| Cash Flow from Financing | -62.6240 | -60.4130 | -120.6430 | -50.6280 | -131.2080 | ||||||
| Decrease / Increase in Cash | -45.5390 | 24.4410 | 40.6050 | -10.8180 | -32.0400 | ||||||
| Employees | 3,225 | 3,107 | 3,136 | 3,216 | 3,004 | ||||||
